J. Frank Harmon

Filings by J. Frank Harmon span 2 companies, the busiest being Abraxis BioScience, Inc. (ABBI) and Sagent Pharmaceuticals, Inc. The record holds 6 filings, for trades running from 12 December 2006 to 29 August 2016.

On the market, this insider has only sold: 1 sale, €77k in total. The rest of the record consists of 2 share grants.

On 31 August 2016 came the latest disclosure, a transaction for €173k in Sagent Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.